Integrated clinical approach. Considerations regarding a serious case of multiple echinococcosis
Keywords:
Clinical Approach, echinococcosis, “Evidence-Based Medicine”Abstract
The author counts himself among the internal medical practitioners
that have taken a serious interest in the growing “programming”
of the clinical practice, bearing in mind that utilizing the guidelines and “Evidence-Based Medicine” - often in an uncritical and
passive manner – has contributed significantly for a standardized
approach to the treatment of patients. On the other hand, there are
more and more important breakthroughs in Biomedical Research
(immunology, immunogenetics, etc.) and medical practitioners are
slow in integrating these breakthroughs into their daily clinical
practice. For this reason, this study proposes a holistic handling of
the patient — which the author calls Integrated Clinical Approach
— and, to illustrate this “methodology” in a concrete manner, he
offers an example of the study and treatment of a serious case of multiple cystic echinococcosis.
Downloads
References
David de Morais JA. Estudo epidemiológico da Equinococose-Hidatidose no distrito de Évora: problemática metodológica. Rev Port Doenç Infec 1997; 20(3): 137-45.
David de Morais JA. A Hidatidologia em Portugal. Lisboa: Fundação Calouste Gulbenkian 1998.
Thompson RCA, Lymbery AJ, Constantine CC. Variation in Echinococcus: Towards a Taxonomic Revision of the Genus. Advances in Parasitology 1995; 35: 145-76.
D’Alessandro A. Polycistic echinococcosis in Tropical America: Echinococcus vogeli and E. oligarthrus. Acta Tropica 1997; 67: 43-65.
Eckert J, Thompson RC. Intraspecific variation of Echinococcus granulosus and related species with emphasis on their infectivity to humans. Acta Tropica 1997; 64(1-2): 19-34.
Mattiucci S, David de Morais JA, Arru E, D’Amelio S, Orecchia P, Paggi L. Genetic homogeneity within Echinococcus granulosus from sheep and cattle of portuguese and italian origin. XV Extraordinary International Congress of Hydatidology. Roma 1991.
David de Morais JA, Pratas ML, Pratas AS. Quisto hidático intra-abdominal associado a úlcera duodenal: a propósito de um caso que evoluiu para a perfuração. Rev Portuguesa Doenç Infec 1980; 3(3): 2332-42.
David de Morais JA. Hidatidose hepática e síndrome de Budd-Chiari: caso clínico. In: Vários. Hidatidologia, Libro V. Cordoba: Asociación Española de Hidatidologia 1988: 99-102.
David de Morais JA, Soares de Azevedo JM. Nova abordagem terapêutica da Hidatidose óssea: a propósito de um caso de quisto hidático da tíbia. In: Vários. Hidatidologia, Libro VI. Merida: Asociación Española de Hidatidologia 1990: 393-401.
David de Morais JA. Chemotherapy of Hydatid disease with Albendazole. Rev Port Doenç Infec 1992; 15(2): 95-98.
David de Morais JA. Hidatidose hepática e sindroma de Budd-Chiari. A propósito de um caso clínico tratado com Mebendazol. Rev Portuguesa Doenç Infec 1997; 20(1): 63-67.
David de Morais JA, Heitor da Fonseca, Correia J. Abcessos piogénicos do fígado versus quistos hidáticos supurados. Rev Portuguesa Doenç Infec 1997; 20(3): 181-185.
David de Morais JA, Diaz-Gonçalves M, Valadas E. Quisto hidático do pâncreas: uma localização excepcional da hidatidose. Rev Portuguesa Doenç Infec 1998; 21: 114-119.
David de Morais JA. Hidatidose “universal” subsequente a traumatismo do abdómen. Rev Portuguesa Doenç Infec 1999; 22: 47-51.
David de Morais JA. Hidatidose esplénica: 20 anos de experiência epidémico-clínica. Rev Portuguesa Doenç Infec 2000; 23: 167-174.
David de Morais. Hidatidose abdominal secundária a acidentes traumáticos: a nossa experiência de 20 anos em área endémica. Rev Portuguesa Doenç Infec 2002; 1, 2ª série (1): 6-15.
Valadas E, Lopes ML, David de Morais JA. Estudo da imunidade celular num grupo de doentes com hidatidose. Rev Soc Méd Hosp Dist Zona Sul 1990; 5(3): 180-184.
Segall M, Bach FH. HLA and disease. N Eng J Med 1990; 322(26): 1879-1881.
MacDonald KS, Fowke KR, Kimani J, Dunand VA, Nagelkerke NJD, Ball TB et al. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 2000, 181: 1581-1589.
Diepolder HM, Scholz S, Pape GR. Influence of alleles on outcome of hepatitis C virus infection. Lancet 1999; 354: 2094.
Thursz M, Yallop R, Goldin R, Trepo C, Thomas H. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. Lancet 1999; 354: 2119-2124.
McNicholl J. Host genes and infectious diseases. Emerging Infectious Diseases 1998; 4(3): 423-426.
Pareja E, Bonal FJ, Paule P, Salvatierra D, Garrido F. HLA antigens in brucellosis. Exp Clin Immunogenet 1985; 2(1): 1-3.
Hillhouse E. Mecanismos de imunidade nos processos patológicos. Hospital Update 1994; 1(6): 5-6.
Mackay I, Rosen FS. The HLA system. Part II. N Eng J Med 2000; 343(11): 782-786.
Hill AVS, Elvin J, Willis AC, Aidoo M, Allsopp CEM, Gotch FM et al. Molecular analysis of the association of HLA-B53 and resistance to severe
malaria. Nature 1992; 360: 434-439.
Steere AC, Dwyer E, Winchester R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 allels. N Eng J Med 1990; 323: 219-223.
Bianchi G, Rovetta G. Differences in Clinical Patterns of Lyme Borreliosis. In: Cevenini R, Sambri V, La Placa M, edit. Advances in Lyme Borreliosis Research (Proceedings of the VI International Conference on Lyme Borreliosis). Bologna (Italy): Societá Editrice Esculapio 1994: 148-151.
David de Morais JA, Leitão AL, Páscoa BG, Filipe AR, Núncio MS. Doença de Lyme. A nossa experiência clínica na região do Alentejo. Rev Port Doenç Infec 1992; 15: 227-245.
David de Morais JA, Núncio MS, Filipe AR, Dias A, Henriques R. Acidente vascular cerebral isquémico por neuroborreliose de Lyme. Rev Port Doenç Infec 1999; 22(3-4): 201-208.
Del Brutto OH, Granados G, Talamas O, Sotelo J, Gorodezky C. Genetic pattern of the HLA system: HLA A, B, C, DR, and DQ antigens in Mexican patients with parenchymal brain cysticercosis. Hum Biol 1991; 63: 85-93.
McNicholl J. Host genes and infectious diseases. Emerging Infectious Diseases 1998; 4(3): 423-426.
Xu XP, Li SB, Wang CY, Li OH. Study on the association of HLA with pulmonary tuberculosis. Immunol Invest 1986; 15: 327-332.
Assaad-Khalil SH, Helmy MAS, Zaki A, Mikhail MM, El-Hai MA, El-Sawy M. Some genetic, clinical and immunologic interrelations in schistosomiasis mansoni. Ann Biol Clin 1993; 51: 619-626.
Hillhouse E. Mecanismos de imunidade nos processos patológicos. Hospital Update 1994; 1(6): 5-6.
Czarnecki D, Zalgberg J, Nicholson I, Tait B. Skin cancer and HLA antigens. N Eng J Med 1992; 326(11): 765.
Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Eng J Med 1978; 298(16): 869-871.
Godot V, Harraga S, Beurton I, Tiberghien P, Sarciron E, Gottstein B et al. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine in humans. II. Influence of the HLA B8, DR3, DQ2 haplotype. Clin Exp Immunol 2000; 121(3): 491-498.
Azab ME, Bishara SA, Ramzy RM, Oteifa NM, El-Hoseiny LM, Ahmed MA. The evaluation of HLA-DRB1 antigens as susceptibility markers for
unilocular cystic echinococcosis in Egyptian patients. Parasitol Res 2004; 92(6): 473-477.
Azab ME, Bishara SA, Helmy H, Oteifa NM, El-Hoseiny LM, Ramzy RM et al. Association of some HLA-DRB1 antigens with Echinococcus granulosus specific humoral immune response. J Egypt Soc Parasitol 2004; 34(1): 183-196.
Eiermann TH, Bettens F, Tiberghien P, Beurton I, Bresson-Hadni S, Vuitton D-A et al. Analysis of the HLA class II antigens in 150 patients of the Jura endemic area with alveolar echinococcosis. In: Meeting of the WHO Informal Working group on Echinococcosis. Applications of molecular biology techniques to studies on Echinococcosis (abstracts). Limassol, Cyprus, Nov. 8, 1995.
Li F, Shi Y, Shi D, Vuitton DA, Craig PS. HLA-DRB1 allele in 35 patients with alveolar echinococcosis in Gansu Province of China. Chin Med J 2003; 116(10): 1557-1560.
David de Morais JA. Chemotherapy of Hidatid disease with albendazole. First clinical trial carried out in Portugal. Archivos de la Hidatidosis (Roma) 1991; 30: 1207-1211.
David de Morais JA. Tratamento médico da Hidatidose. Boletim Hospital Pulido Valente 1992; 5(2): 120 -127.
Levy J. Levamisole and Cellular Immunity in Rheumatoid Arthritis - Clinical and Laboratorial Correlates. The Journal of Rheumatology 1978; 5(4): 63-68.
Brugmans, J. Levamisole in Infectious Diseases - a Review of the Literature. The Journal of Rheumatology 1978; 5(4): 115-121.
Garzón MC, Mubita M, Kachinka L. Levamisole treatment in HIV-infected Zambian children. Lancet 1992; 340: 1099-1100.
Kashuba EA, Krylov VI. Change in immune response in children suffering from opisthorchosis and attempt at its correction using Levamisol. J Hyg Epidemiol Microbiol Immunol 1984; 28(3): 345-352.
Ruuskanen O, Remes M, Mákela A-L, Isomäki H, Toivanen A. Levamisole and agranulocytosis. Lancet 1976; ii (7992): 958-959.
Clara R, Germanes. Levamisole and agranulocytosis. Lancet 1977; i (8001): 47-48.
Veys EM, Mielants H, Verbruggen G. Levamisole-induced adverse reactions in HLA B27-positive rheumatoid arthritis. Lancet 1978; i (8056): 148.
Siracusano A. Immunology and immunopathology of Echinococcus granulosus and Echinococcus multilocularis infections. Archivos Internacionales de la Hidatidosis (XVIII Congress of Hydatidology, Lisboa) 1997; 32: 132-135.
Craig PS. Asymptomatic CE Patient Management: Immunologic Contributions. Archivos Internationales de la Hidatidosis (XIX International Congress of Hydatidology, Argentina) 1999; 33: 196-197.
WHO Informal Working Group. International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. Acta Tropica 2003; 85; 253-261.
Devereux, Georges. Ethnopsychanalyse Complémentariste. Paris: Flammarion, 1972.
Chaput M, LeSauteur T. Dossier Pollution. Montréal: Éditions du Jour, 1971, p. 25.
Fernando Pessoa. Santo António. São João. São Pedro. Lisboa: A Regra do Jogo, 1986, p. 100.
Naylor CD. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet 1995; 345: 840-842.
Sá J, Parente F, Ferreira F, Silva EG, Ferreira AF, Sá A, Fonseca I et al. Contributo para o conhecimento da actividade dos Serviços de Medicina Interna em Portugal - Inquéritos de avaliação das idoneidades formativas. Revista Ordem dos Médicos 2005; 21: 22-28.
David de Morais JA. Relação Médico/Paciente. O Internista, o Clínico Geral e a Medicina Psicossomática. Revista Portuguesa de Clínica Geral 1989; 6(11): 322-329; 6(12): 366-371 e 380.
David de Morais JA. Breves nótulas médico-antropológicas sobre o tratamento vernáculo do “cobro” (herpes zóster) no Alentejo. Medicina Interna 2005; 12(2): 56-62.
Veloso, António José de Barros. Acerca da “Medicina Baseada na Evidência”. Revista da Ordem dos Médicos 2005; 21(61): 24-33.
Osswald, Walter. I Jornadas da Sociedade Portuguesa do AVC. In: Notícias Médicas, nº 2897, 15 de Março de 2006:16-18.
Giustini D. Como é que o Google está a mudar a Medicina. BMJ (edição em língua portuguesa) 2006; 15 (2): 71-72
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
